These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18358120)

  • 1. [Evolution of serologically confirmed cases of mumps in the Madrid community, Spain, during a period of 7 years (2000--2006)].
    Sanz JC; de Ory F; Fernández M; Herranz N; Méndez N; Ramírez R
    Med Clin (Barc); 2008 Mar; 130(8):292-4. PubMed ID: 18358120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An outbreak of mumps in a high school: Estimation of vaccine effectiveness. Zaragoza 2011].
    Compés-Dea C; Guimbao-Bescós J; Gaspar-Escayola JI; Lázaro-Belanche MÁ; Aznar-Brieba A
    Enferm Infecc Microbiol Clin; 2015; 33(6):385-90. PubMed ID: 25475656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of the detection of IgA antibodies to the laboratory diagnosis of mumps in the population with a high vaccination coverage].
    Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Malý M
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):16-9. PubMed ID: 25872991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mumps control today.
    Quinlisk MP
    J Infect Dis; 2010 Sep; 202(5):655-6. PubMed ID: 20662719
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection.
    Sakata R; Nagita A; Kidokoro M; Kato A; Ogino K
    Pediatr Res; 2015 Nov; 78(5):580-4. PubMed ID: 26267156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G.
    Narita M; Matsuzono Y; Takekoshi Y; Yamada S; Itakura O; Kubota M; Kikuta H; Togashi T
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):799-803. PubMed ID: 9801337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mumps in a urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures].
    de los Ríos Martín R; García Marín N; Sanz Moreno J; Ballester Orcal E
    Aten Primaria; 2001 Jun; 28(1):10-6. PubMed ID: 11412572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comment on: Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D: Studies of the mumps epidemic in vaccinated children in Western Switzerland].
    Gasser-Bachmann M
    Schweiz Med Wochenschr; 1997 Nov; 127(47):1970-1. PubMed ID: 9480538
    [No Abstract]   [Full Text] [Related]  

  • 10. [Laboratory diagnosis of parotitis in the post-vaccination era].
    de la Loma A; Villota J; Varela JM; Alonso M; de Ory F
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):119-20. PubMed ID: 12586040
    [No Abstract]   [Full Text] [Related]  

  • 11. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
    Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
    Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
    Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
    Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mumps outbreak in the Plzeň Region in 2011].
    Pazdiora P; Skálová J; Kubátová A; Ježová I; Morávková I; Podlesná I; Průchová J; Spáčilová M; Švecová M
    Epidemiol Mikrobiol Imunol; 2015 Oct; 64(4):242-9. PubMed ID: 26795229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and efficacy of Hoshino strain of mumps vaccine in Iran; two years study.
    Avijgan M; Hafizi M; Moghni M; Kheiri S; Esteghamati A; Sarikhani S
    East Afr J Public Health; 2011 Jun; 8(2):88-91. PubMed ID: 22066292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional outbreak of mumps due to genotype H in Korea in 1999.
    Lee JY; Na BK; Kim JH; Lee JS; Park JW; Shin GC; Cho HW; Lee HD; Gou UY; Yang BK; Kim J; Kang C; Kim WJ
    J Med Virol; 2004 May; 73(1):85-90. PubMed ID: 15042653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mumps vaccine virus transmission].
    Otrashevskaia EV; Kulak MV; Otrashevskaia AV; Karpov IA; Fisenko EG; Ignat'ev GM
    Vopr Virusol; 2013; 58(6):42-5. PubMed ID: 24772647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mumps outbreak among young people in Northern Ireland.
    Reaney EA; Tohani VK; Devine MJ; Smithson RD; Smyth B
    Commun Dis Public Health; 2001 Dec; 4(4):311-5. PubMed ID: 12109401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of anti-mumps IgG antibodies in a pediatric population].
    Suárez J; Castañeda MR; Gutiérrez C; Tascón R; Rodríguez EF
    Enferm Infecc Microbiol Clin; 1992 Mar; 10(3):130-4. PubMed ID: 1576184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Age distribution of the incidence and immune structure of the pediatric population in epidemic parotitis].
    Lazikova GF; Vardanian NV; Nikolaevskiĭ GP
    Vopr Virusol; 1979; (1):64-6. PubMed ID: 419741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.